To improve CAR-T therapy for glioblastoma, a new TanCAR, comprising the tandem arrangement of IL13 and EphA2 scFv, was generated and validated in vitro and in vivo.
[Molecular Therapy-Oncolytics]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
172086
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
